Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis.
Yoshida Y, Hashimoto N, Tokuyama Y, Kitagawa H, Takahashi K, Yagui K, Kanatsuka A, Bujo H, Higurashi M, Miyazawa S, Yoshida S, Saito Y. Yoshida Y, et al. Among authors: hashimoto n. Metabolism. 2004 Sep;53(9):1095-100. doi: 10.1016/j.metabol.2004.04.002. Metabolism. 2004. PMID: 15334366 Clinical Trial.
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).
Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V Study Group. Koshizaka M, et al. Among authors: hashimoto n. Diabetes Obes Metab. 2019 Aug;21(8):1990-1995. doi: 10.1111/dom.13750. Epub 2019 May 8. Diabetes Obes Metab. 2019. PMID: 30993861 Free PMC article. Clinical Trial.
Hyperferritinemia Is a Predictor of Onset of Diabetes in Japanese Males Independently of Decreased Renal Function and Fatty Liver: A Fifteen-Year Follow-Up Study.
Sakuma Y, Ogino J, Iwai R, Inoue T, Takahashi H, Suzuki Y, Kinoshita D, Takemura K, Takahashi H, Shimura H, Sato Y, Yoshida S, Hashimoto N. Sakuma Y, et al. Among authors: hashimoto n. J Clin Med Res. 2021 Dec;13(12):541-548. doi: 10.14740/jocmr4635. Epub 2021 Dec 28. J Clin Med Res. 2021. PMID: 35059072 Free PMC article.
Sex differences in predictive factors for onset of type 2 diabetes in Japanese individuals: A 15-year follow-up study.
Yoshimoto M, Sakuma Y, Ogino J, Iwai R, Watanabe S, Inoue T, Takahashi H, Suzuki Y, Kinoshita D, Takemura K, Takahashi H, Shimura H, Babazono T, Yoshida S, Hashimoto N. Yoshimoto M, et al. Among authors: hashimoto n. J Diabetes Investig. 2023 Jan;14(1):37-47. doi: 10.1111/jdi.13918. Epub 2022 Oct 6. J Diabetes Investig. 2023. PMID: 36200977 Free PMC article.
[Case report: successful treatment with liraglutide in an insulin allergic patient with liver cirrhosis, hepatocellular carcinoma and poor glycemic control using high dose of insulin].
Fukushima S, Kawaguchi Y, Tajima K, Ichimura Y, Ogino J, Takeuchi M, Kawamura S, Morohoshi S, Kosaka Y, Hashimoto N. Fukushima S, et al. Among authors: hashimoto n. Nihon Naika Gakkai Zasshi. 2013 Jun 10;102(6):1455-7. doi: 10.2169/naika.102.1455. Nihon Naika Gakkai Zasshi. 2013. PMID: 23947212 Japanese. No abstract available.
Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study).
Koshizaka M, Ishikawa K, Ishikawa T, Kobayashi K, Takemoto M, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Tatsuno I, Terano T, Hashimoto N, Kuribayashi N, Uchida D, Yokote K; PRIME-V Study Investigators. Koshizaka M, et al. Among authors: hashimoto n. BMJ Open. 2017 May 9;7(5):e015766. doi: 10.1136/bmjopen-2016-015766. BMJ Open. 2017. PMID: 28490565 Free PMC article. Clinical Trial.
Renal Function During an Open-Label Prospective Observational Trial of Sitagliptin in Patients With Diabetes: A Sub-Analysis of the JAMP Study.
Tomonaga O, Sakura H, Hashimoto N, Sasamoto K, Ohashi H, Hasumi S, Ujihara N, Kasahara T, Nunome H, Honda M, Iwamoto Y; JAMP Study Investigators. Tomonaga O, et al. Among authors: hashimoto n. J Clin Med Res. 2018 Jan;10(1):32-40. doi: 10.14740/jocmr3225w. Epub 2017 Dec 1. J Clin Med Res. 2018. PMID: 29238432 Free PMC article.
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study).
Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V study group. Koshizaka M, et al. Among authors: hashimoto n. J Diabetes Investig. 2021 Feb;12(2):200-206. doi: 10.1111/jdi.13340. Epub 2020 Aug 20. J Diabetes Investig. 2021. PMID: 32623839 Free PMC article. Clinical Trial.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial.
Yokoh H, Kobayashi K, Sato Y, Takemoto M, Uchida D, Kanatsuka A, Kuribayashi N, Terano T, Hashimoto N, Sakurai K, Hanaoka H, Ishikawa K, Onishi S, Yokote K. Yokoh H, et al. Among authors: hashimoto n. J Diabetes Investig. 2015 Mar;6(2):182-91. doi: 10.1111/jdi.12282. Epub 2014 Sep 24. J Diabetes Investig. 2015. PMID: 25802726 Free PMC article.
2,422 results